-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Moleculin Biotech, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2016 to Q4 2024.
- Moleculin Biotech, Inc. Return On Equity for the quarter ending December 31, 2024 was -165 %, a 104% decline year-over-year.
- Moleculin Biotech, Inc. annual Return On Equity for 2024 was -165 %, a 104% decline from 2023.
- Moleculin Biotech, Inc. annual Return On Equity for 2023 was -80.9 %, a 74% decline from 2022.
- Moleculin Biotech, Inc. annual Return On Equity for 2022 was -46.5 %, a 144% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)